BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22952554)

  • 1. Molecular signature in HCV-positive lymphomas.
    De Re V; Caggiari L; Garziera M; De Zorzi M; Repetto O
    Clin Dev Immunol; 2012; 2012():623465. PubMed ID: 22952554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-cell receptors expressed by lymphomas of hepatitis C virus (HCV)-infected patients rarely react with the viral proteins.
    Ng PP; Kuo CC; Wang S; Einav S; Arcaini L; Paulli M; Portlock CS; Marcotrigiano J; Tarr A; Ball J; Levy R; Levy S
    Blood; 2014 Mar; 123(10):1512-5. PubMed ID: 24449209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower expression of CD81 B-cell receptor in lymphoproliferative diseases associated with hepatitis C virus infection.
    Cacoub P; Bourlière M; Hausfater P; Charlotte F; Khiri H; Toci S; Piette JC; Poynard T; Halfon P
    J Viral Hepat; 2003 Jan; 10(1):10-5. PubMed ID: 12558906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-cell-intrinsic hepatitis C virus expression leads to B-cell-lymphomagenesis and induction of NF-κB signalling.
    Kasama Y; Mizukami T; Kusunoki H; Peveling-Oberhag J; Nishito Y; Ozawa M; Kohara M; Mizuochi T; Tsukiyama-Kohara K
    PLoS One; 2014; 9(3):e91373. PubMed ID: 24651473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management.
    Peveling-Oberhag J; Arcaini L; Hansmann ML; Zeuzem S
    J Hepatol; 2013 Jul; 59(1):169-77. PubMed ID: 23542089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activation of the nuclear factor kappa B--key role in oncogenesis? Chronic hepatitis C virus infection and lymphomagenesis].
    Gasztonyi B; Pár A; Kiss K; Kereskai L; Szomor A; Szeberényi J; Pajor L; Mózsik G
    Orv Hetil; 2003 May; 144(18):863-8. PubMed ID: 12785239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders.
    Landau DA; Rosenzwajg M; Saadoun D; Klatzmann D; Cacoub P
    Ann Rheum Dis; 2009 Mar; 68(3):337-44. PubMed ID: 18434450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HCV-associated lymphomas.
    Fiorilli M; Mecucci C; Farci P; Casato M
    Rev Clin Exp Hematol; 2003 Dec; 7(4):406-23. PubMed ID: 15129650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: viral detection in gastric low-grade lymphoma associated with autoimmune disease and in chronic gastritis.
    De Vita S; De Re V; Sansonno D; Sorrentino D; Corte RL; Pivetta B; Gasparotto D; Racanelli V; Marzotto A; Labombarda A; Gloghini A; Ferraccioli G; Monteverde A; Carbone A; Dammacco F; Boiocchi M
    Hepatology; 2000 Jan; 31(1):182-9. PubMed ID: 10613744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
    Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
    J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus upregulates B-cell receptor signaling: a novel mechanism for HCV-associated B-cell lymphoproliferative disorders.
    Dai B; Chen AY; Corkum CP; Peroutka RJ; Landon A; Houng S; Muniandy PA; Zhang Y; Lehrmann E; Mazan-Mamczarz K; Steinhardt J; Shlyak M; Chen QC; Becker KG; Livak F; Michalak TI; Talwani R; Gartenhaus RB
    Oncogene; 2016 Jun; 35(23):2979-90. PubMed ID: 26434584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of aberrant somatic hypermutation (SHM) in non-Hodgkin's lymphomas of patients with chronic HCV infection.
    Libra M; Capello D; Gloghini A; Laura P; Berra E; Cerri M; Gasparotto D; Franca S; De Re V; Gaidano G; Carbone A
    J Pathol; 2005 May; 206(1):87-91. PubMed ID: 15809970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tonic B cell antigen receptor signals supply an NF-kappaB substrate for prosurvival BLyS signaling.
    Stadanlick JE; Kaileh M; Karnell FG; Scholz JL; Miller JP; Quinn WJ; Brezski RJ; Treml LS; Jordan KA; Monroe JG; Sen R; Cancro MP
    Nat Immunol; 2008 Dec; 9(12):1379-87. PubMed ID: 18978795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of the NF-κB Pathway in B-Lymphocyte Biology.
    Sasaki Y; Iwai K
    Curr Top Microbiol Immunol; 2016; 393():177-209. PubMed ID: 26275874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cells in chronically hepatitis C virus-infected individuals lack a virus-induced mutation signature in the TP53, CTNNB1, and BCL6 genes.
    Tucci FA; Broering R; Johansson P; Schlaak JF; Küppers R
    J Virol; 2013 Mar; 87(5):2956-62. PubMed ID: 23269799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of hepatitis C virus RNA sequences in B-cell non-Hodgkin lymphoma.
    Karavattathayyil SJ; Kalkeri G; Liu HJ; Gaglio P; Garry RF; Krause JR; Dash S
    Am J Clin Pathol; 2000 Mar; 113(3):391-8. PubMed ID: 10705820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between hepatitis C virus infection, genetic polymorphisms of oxidative stress genes and B-cell non-Hodgkin's lymphoma risk in Egypt.
    Farawela H; Khorshied M; Shaheen I; Gouda H; Nasef A; Abulata N; Mahmoud HA; Zawam HM; Mousa SM
    Infect Genet Evol; 2012 Aug; 12(6):1189-94. PubMed ID: 22522002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced RIG-I expression is mediated by interferon regulatory factor-2 in peripheral blood B cells from hepatitis C virus-infected patients.
    Masumi A; Ito M; Mochida K; Hamaguchi I; Mizukami T; Momose H; Kuramitsu M; Tsuruhara M; Takizawa K; Kato A; Yamaguchi K
    Biochem Biophys Res Commun; 2010 Jan; 391(4):1623-8. PubMed ID: 20034464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR9 signalling in HCV-associated atypical memory B cells triggers Th1 and rheumatoid factor autoantibody responses.
    Comarmond C; Lorin V; Marques C; Maciejewski-Duval A; Joher N; Planchais C; Touzot M; Biard L; Hieu T; Quiniou V; Desbois AC; Rosenzwajg M; Klatzmann D; Cacoub P; Mouquet H; Saadoun D
    J Hepatol; 2019 Nov; 71(5):908-919. PubMed ID: 31279905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role.
    Zignego AL; Ferri C; Giannini C; La Civita L; Careccia G; Longombardo G; Bellesi G; Caracciolo F; Thiers V; Gentilini P
    Arch Virol; 1997; 142(3):545-55. PubMed ID: 9349300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.